<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Relationship of serum uric acid, serum creatinine and serum cystatin C with maternal and fetal outcomes in rural Indian pregnant women</title>
			</titleStmt>
			<publicationStmt>
				<publisher>Medip Academy</publisher>
				<availability status="unknown"><p>Copyright Medip Academy</p>
				</availability>
				<date>November 16.</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Padma</forename><surname>Yalamati</surname></persName>
							<email>padma.md@hotmail.com</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Biochemistry</orgName>
								<orgName type="institution" key="instit1">SHARE INDIA</orgName>
								<orgName type="institution" key="instit2">Mediciti Institute of Medical Sciences</orgName>
								<address>
									<settlement>Ghanpur</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Medchal Mandal, R. R. District</orgName>
								<address>
									<settlement>Telangana</settlement>
									<region>Hyderabad</region>
									<country key="IN">India</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Aparna</forename><surname>Bhongir</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kalpana</forename><surname>Betha</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Obstetrics &amp; Gynaecology</orgName>
								<orgName type="institution" key="instit1">SHARE INDIA</orgName>
								<orgName type="institution" key="instit2">Mediciti Institute of Medical Sciences</orgName>
								<address>
									<settlement>Ghanpur</settlement>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="institution">Medchal Mandal, R. R. District</orgName>
								<address>
									<settlement>Telangana</settlement>
									<region>Hyderabad</region>
									<country key="IN">India</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ritika</forename><surname>Verma</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Biochemistry</orgName>
								<orgName type="institution" key="instit1">SHARE INDIA</orgName>
								<orgName type="institution" key="instit2">Mediciti Institute of Medical Sciences</orgName>
								<address>
									<settlement>Ghanpur</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Medchal Mandal, R. R. District</orgName>
								<address>
									<settlement>Telangana</settlement>
									<region>Hyderabad</region>
									<country key="IN">India</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shailendra</forename><surname>Dandge</surname></persName>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Department of Pharmacology</orgName>
								<orgName type="department" key="dep2">SHARE INDIA</orgName>
								<orgName type="institution">Mediciti Institute of Medical Sciences</orgName>
								<address>
									<settlement>Ghanpur</settlement>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="institution">Medchal Mandal, R. R. District</orgName>
								<address>
									<settlement>Telangana</settlement>
									<region>Hyderabad</region>
									<country key="IN">India</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Relationship of serum uric acid, serum creatinine and serum cystatin C with maternal and fetal outcomes in rural Indian pregnant women</title>
					</analytic>
					<monogr>
						<title level="j" type="main">International Journal of Reproduction, Contraception, Obstetrics and Gynecology</title>
						<title level="j" type="abbrev">Int J Reprod Contracept Obstet Gynecol</title>
						<idno type="ISSN">2320-1770</idno>
						<imprint>
							<publisher>Medip Academy</publisher>
							<biblScope unit="page" from="1505" to="1510"/>
							<date type="published">November 16.</date>
						</imprint>
					</monogr>
					<idno type="DOI">10.18203/2320-1770.ijrcog20150737</idno>
					<idno type="PMID">26583159</idno>
					<idno type="PMCID">PMC4646224</idno>
					<ptr type="open-access" target="http://www.ijrcog.org/index.php/ijrcog/article/download/2165/1891" />
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-13T22:57+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Uric acid</term>
					<term>Creatinine</term>
					<term>Cystatin C</term>
					<term>Gestational Hypertension</term>
					<term>Preeclampsia</term>
					<term>Gestational age</term>
					<term>Birth weight</term>
					<term>Caesarian section</term>
					<term>Logistic regression</term>
				</keywords>
			</textClass>
			<abstract>
				<p>Background-Hypertensive disorders are the most common in pregnancy. Several studies showed a positive correlation between elevated maternal serum uric acid (UA), serum creatinine and adverse maternal and fetal outcomes, but only a few studies are available on serum cystatin C and maternal and fetal outcomes. The present study was undertaken to study the association of serum UA, creatinine and cystatin C with maternal and fetal outcomes. Methods-Out of 116 pregnant women 69 women had no hypertension and 47 had hypertension with or without proteinuria. Serum UA, creatinine and cystatin C was measured by modified Uricase method, modified kinetic Jaffe&apos;s reaction and particle-enhanced immunonephelometric assay respectively. Multivariate logistic regression was performed to determine the independent effects of serum UA, creatinine and cystatin C on maternal and fetal outcomes using stata 13.1. Results-The adjusted odds ratio (OR) was 3.73 (95% CI: 1.18-11.75; P=0.024) for UA; 15.79 (95% CI: 3.04-81.94; P=0.001) for creatinine and 2.03 (95% CI: 0.70-5.87; P=0.192) for cystatin C in hypertensive disorders of pregnancy. All the three renal parameters were not significantly associated with birth weight, gestational age of delivery and mode of delivery after adjusting for the confounding factors. Conclusions-Serum creatinine and uric acid are independent risk factors for hypertensive disorders of pregnancy. High serum uric acid is associated with low birth weight and delivery by caesarian section whereas high serum creatinine with preterm delivery only before adjustment for This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTRODUCTION</head><p>Hypertensive disorders account for approximately 2%-10% of all pregnancies. <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b1">2</ref> Among these pre-eclampsia (PE) is one of the major causes of maternal and perinatal morbidity and mortality worldwide whereas uncomplicated gestational hypertension has a better prognosis. Gestational hypertension is defined as the new onset gestational hypertension after the 20 <ref type="bibr">th</ref> week of gestation but without proteinuria. <ref type="bibr" target="#b2">3</ref> PE is characterized by new onset gestational hypertension after the 20 <ref type="bibr">th</ref> week of gestation, proteinuria and impaired renal function. <ref type="bibr" target="#b2">3</ref> Due to hormonal and hemodynamic changes of pregnancy, renal function is altered and more so in hypertensive disorders and hence these changes must be considered when assessing renal function in pregnancy. Serum Uric acid (UA), serum creatinine and more recently serum cystatin C levels are the indices of renal function. Several studies have reported a positive correlation between elevated maternal serum UA, serum creatinine and adverse maternal and fetal outcomes. <ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref> We found one study showing an association of high plasma cystatin C levels and PE which reflects the acute kidney dysfunction associated with PE but we did not find studies showing the relationship between serum cystatin C and the fetal outcomes. <ref type="bibr" target="#b10">11</ref> We hypothesize that elevated levels of serum UA, serum Creatinine and serum cystatin C are associated with adverse maternal and fetal outcomes and hence in our study we would like to evaluate the relationship between the above mentioned parameters and the maternal and fetal outcomes.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>METHODS</head><p>This pilot study was performed on 116 pregnant women in the Department of obstetrics &amp; gynaecology, Mediciti Institute of Medical Sciences, Ghanpur, Ranga Reddy district, Telangana, India. Written informed consent was taken from all included participants. Among them 69 women did not develop hypertension and 47 developed hypertension with or without proteinuria. All of them had no present or past history of hypertension, diabetes mellitus or renal disease. 5 ml of non-fasting venous blood samples were collected at the time of delivery from all the included participants. <ref type="bibr" target="#b9">10</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Measuring parameters-mother</head><p>The blood pressure was measured using an oscillometric digital sphygmomanometer (Model: Omron HEM-780N3). The international society for the study of hypertension in pregnancy guidelines were followed for the measurement of blood pressure. <ref type="bibr" target="#b2">3</ref> Two measurements taken 4 hours apart with systolic blood pressure ≥ 140 mm Hg and diastolic blood pressure ≥ 90 mm Hg was used as the diagnostic criteria for the hypertension in pregnancy. Serum uric acid was measured by modified Uricase method in Dade Behring-Dimension Xpand plus system using uric acid flex reagent cartridge according to the manufacturer's instructions. <ref type="bibr" target="#b11">12</ref> Serum creatinine was measured by modified kinetic Jaffe's reaction in Dade Behring-Dimension Xpand plus system using creatinine flex reagent cartridge according to the manufacturer's instructions. <ref type="bibr" target="#b12">13</ref> Serum cystatin C was measured by a fully automated particle-enhanced immunonephelometric assay (N Latex cystatin C, Dade-Behring, Inc) in BN Pro-Spec nephelometer (Dade Behring, Inc, Deerfield, IL) according to the manufacturer's instructions. 14 Urinary proteins were measured in random mid-stream urine sample by semi-quantitative dip stick method. <ref type="bibr" target="#b15">15</ref> Two readings of 1+ (30 mg/dl) were taken as the diagnostic criteria for pre-eclampsia. <ref type="bibr" target="#b2">3</ref> Further details regarding the methodology were presented previously. <ref type="bibr" target="#b16">16</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Measuring parameters-new-born</head><p>The weight of the new-born was measured by a digital weighing scale (SECA 354/364).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical tools</head><p>The data was entered in a MS-Excel database and was analysed using stata 13.1 statistical software (Stata, College Station, Texas USA). We performed multivariate logistic regression to determine the independent effects of serum UA, serum creatinine and serum cystatin C before and after adjusting for the possible confounding factors on maternal and fetal outcomes. The hypertensive disorders of pregnancy, birth weight, gestational age of delivery and mode of delivery were treated as the dependent variables and serum UA, serum creatinine and serum cystatin C as independent variables. Both dependent and independent variables were dichotomized. Hypertension, birth weight and gestational age of delivery were dichotomized using the standard cut-off values. <ref type="bibr" target="#b2">3,</ref><ref type="bibr" target="#b17">17,</ref><ref type="bibr" target="#b18">18</ref> The cut-offs for dichotomization were taken as 5.88 mg/dl for serum uric acid, 19 0.8 mg/dl for serum creatinine <ref type="bibr" target="#b16">16</ref> and 1.3 mg/L for serum cystatin c. <ref type="bibr" target="#b16">16</ref> Serum uric acid ≥ 5.88 mg/dl, serum creatinine ≥ 0.8 mg/dl and serum cystatin C ≥ 1.3 mg/L were coded as 1 and those less than the cut-offs were coded as 0. For each outcome the first model was unadjusted and the second model was adjusted for the covariates as possible confounders in the analysis. The possible confounders were age, BMI, gestational age, parity and birth weight in the first analysis where hypertensive disorders were taken as the dependent variable <ref type="table">(Table 2)</ref>; age, BMI, gestational age, parity and hypertensive disorders in the second analysis where birth weight was taken as the dependent variable <ref type="table" target="#tab_2">(Table 3)</ref>; age, BMI, parity, birth weight and hypertensive disorders in the third analysis where the gestational age of delivery is the outcome <ref type="table" target="#tab_3">(Table 4)</ref>; age, BMI, parity, birth weight, gestational age and hypertensive disorders in the fourth analysis where mode of delivery was taken as the dependent variable ( <ref type="table" target="#tab_5">Table 5)</ref>. A p value of &lt;0.05 was considered as statistically significant.</p><p>The maternal and child characteristics of the study participants were presented previously in <ref type="table" target="#tab_0">Table 1</ref>. <ref type="bibr" target="#b16">16</ref> The included participants were presently categorized as shown in <ref type="table" target="#tab_0">Table 1</ref>. <ref type="table">Table 2</ref> Shows the results of multivariate logistic regression analysis for hypertensive disorders of pregnancy: pregnant women with high serum uric acid (≥5.88 mg/dl) and high serum creatinine (≥0.8 mg/dl) are at over 3.73 times and 15.79 times respectively, the risk of developing hypertensive disorders compared to the pregnant women with low serum uric acid and low serum creatinine after adjusting for the confounding factors. Hence serum uric acid and serum creatinine are independent risk factors for the development of hypertensive disorders of pregnancy. There was no significant association between serum cystatin C and the development of hypertensive disorders. <ref type="table" target="#tab_2">Table 3</ref> shows the results of multivariate logistic regression analysis for birth weight: pregnant women having high serum uric acid levels (≥5.88 mg/dl) are at over 2.49 times the risk of giving birth to low birth weight babies (&lt;2.5 Kg) compared to the pregnant women with low serum uric acid before adjusting for the confounding factors but not after adjustment. We found no significant association between serum creatinine, serum cystatin C and the birth weight. <ref type="table" target="#tab_3">Table 4</ref> shows the results of multivariate logistic regression analysis for gestational age of delivery: pregnant women with high serum creatinine (≥0.8 mg/dl) are at over 3.60 times the risk of having gestational age of delivery &lt; 37 wks. compared to the pregnant women with low serum creatinine before adjusting for the confounding factors but not after adjustment. Serum UA and serum cystatin C were not significantly associated with the gestational age of delivery. <ref type="table" target="#tab_5">Table 5</ref> shows the results of multivariate logistic regression analysis for mode of delivery: pregnant women with high serum uric acid (≥ 5.88 mg/dl) are at over 2.93 times the risk of undergoing cesarean section compared to the pregnant women with low serum uric acid before adjusting for the confounding factors but not after adjustment. Serum creatinine and serum cystatin C were not significantly associated with the mode of delivery.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p>The association between raised serum uric acid and preeclampsia was first reported in 1917. <ref type="bibr" target="#b20">20</ref> The elevation in serum uric acid and serum creatinine may be attributed to reduced uric acid and creatinine clearance secondary to reduced glomerular filtration rate, increased reabsorption and decreased secretion in women with pre-eclampsia. <ref type="bibr" target="#b21">[21]</ref><ref type="bibr" target="#b22">[22]</ref><ref type="bibr" target="#b23">[23]</ref> The pathophysiologic mechanisms of pre-eclampsia comprising increased trophoblastic tissue shedding, endothelial dysfunction, and reduced blood flow in the fetomaternal unit have also been hypothesized as the underlying cause of hyperuricemia in this condition. <ref type="bibr" target="#b24">24</ref> The elevation in serum cystatin C in pregnancy might be due to increased production due to increase in the number of nucleated cells. <ref type="bibr" target="#b16">16</ref> Several studies have reported a positive correlation between elevated maternal serum uric acid levels and adverse maternal and fetal outcomes. <ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b25">[25]</ref><ref type="bibr" target="#b26">[26]</ref><ref type="bibr" target="#b27">[27]</ref> There was disagreement in serum uric acid and serum creatinine as predictors of hypertensive disorders. Studies done by weerasekara D.S et al, Manjareeka M et al concluded that serum uric acid and serum creatinine are not predictive of pre-eclampsia and Thangaratinam S et al concluded that serum uric acid is not predictive of preeclampsia. <ref type="bibr" target="#b19">19,</ref><ref type="bibr" target="#b23">23,</ref><ref type="bibr" target="#b28">28</ref> However, Studies done by Roberts et al and Bellomo et al found uric acid to be predictive of gestational hypertension. <ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b29">29</ref> Our findings of serum uric acid as an independent risk factor for hypertensive disorders of pregnancy agree with the study done by Gianni Bellomo et al and Roberts et al. <ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b29">29</ref> We did not observe any significant association between serum cystatin C and the development of hypertensive disorders in contrast to the study done by Franceschini et al. <ref type="bibr" target="#b10">11</ref> There are studies to show the association of high serum uric acid levels with the preterm delivery and small for gestational age but in our study we found an association between high serum creatinine (≥ 0.8 mg/dl) and preterm delivery but not with high serum uric acid and serum cystatin C. <ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b30">30</ref> Also we found in our study that pregnant women with high uric acid levels (≥ 5.88 mg/dl) are associated with low birth weight (&lt;2.5 kg) similar to the studies done by Akahori et al, Sagen et al and Schuster et al but serum creatinine and serum cystatin C were not found to be associated with low birth weight. <ref type="bibr" target="#b31">[31]</ref><ref type="bibr" target="#b32">[32]</ref><ref type="bibr" target="#b33">[33]</ref> Our findings of high uric acid levels associated with caesarian section agree with the study done by Patel et al. <ref type="bibr" target="#b30">30</ref> The variability in the findings can be explained by the differences in the population, definitions of hypertensive disorders of pregnancy and test cut-off values. Our study is limited by the small sample size for each hypertensive disorder group of pregnant women. Also the associations of the three renal parameters with maternal outcomes like the complications of PE and fetal outcomes like Intra Uterine Growth Retardation (IUGR), still births, neonatal deaths, small for gestational age (SGA) and Apgar score have not been studied.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CONCLUSIONS</head><p>We have observed that serum creatinine and serum uric acid is independent risk factors for developing hypertensive disorders in pregnant women. High serum uric acid levels are associated with low birth weight and delivery by caesarian section whereas high serum creatinine levels are associated with preterm delivery in pregnant women only before adjustment for confounding factors and not after adjustment. Serum cystatin C was not found to be significantly associated with the studied maternal and fetal outcomes. Further large scale cohort studies are required to study the association between the three renal parameters and all the maternal and fetal outcomes.  <ref type="table">Table 2</ref> Multivariate logistic regression.   Multivariate logistic regression.  </p></div><figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc>Categorization of included participants.</figDesc><table><row><cell cols="2">No. Dependent variable</cell><cell>N</cell></row><row><cell>1</cell><cell>Blood pressure &lt;140/90 mm Hg</cell><cell>69</cell></row><row><cell></cell><cell>Blood pressure ≥140/90 mm Hg with or</cell><cell>47</cell></row><row><cell></cell><cell>without proteinuria</cell><cell></cell></row><row><cell>2</cell><cell>Birth weight (Kg) &lt;2.5</cell><cell>35</cell></row><row><cell></cell><cell>Birth weight (Kg) ≥2.5</cell><cell>81</cell></row><row><cell>3</cell><cell>Gestational age of delivery (wks.) &lt;37</cell><cell>17</cell></row><row><cell></cell><cell>Gestational age of delivery (wks.) ≥37</cell><cell>99</cell></row><row><cell>4</cell><cell>Mode of delivery: vaginal</cell><cell>87</cell></row><row><cell></cell><cell>Mode of delivery: caesarean section</cell><cell>29</cell></row><row><cell></cell><cell>Independent variable</cell><cell></cell></row><row><cell>1</cell><cell>Serum uric acid ≥ 5.88 mg/dl</cell><cell>26</cell></row><row><cell></cell><cell>Serum uric acid &lt;5.88 mg/dl</cell><cell>90</cell></row><row><cell>2</cell><cell>Serum creatinine ≥ 0.8 mg/dl</cell><cell>19</cell></row><row><cell></cell><cell>Serum creatinine &lt; 0.8 mg/dl</cell><cell>97</cell></row><row><cell>3</cell><cell>Serum cystatin C ≥ 1.3 mg/L.</cell><cell>25</cell></row><row><cell></cell><cell>Serum cystatin C &lt; 1.3 mg/L.</cell><cell>91</cell></row></table><note></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3</head><label>3</label><figDesc>Multivariate logistic regression.</figDesc><table><row><cell>Birth weight #</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Model 1</cell><cell></cell><cell>Model 2 *</cell><cell></cell></row><row><cell>Parameter</cell><cell>Unadjusted</cell><cell>P-</cell><cell>Adjusted</cell><cell>P-</cell></row><row><cell></cell><cell>OR (95% CI β )</cell><cell>value</cell><cell>(95% CI) OR *</cell><cell>value</cell></row><row><cell>Serum uric acid (mg/dl)</cell><cell>2.49 (1.01 -6.17)</cell><cell cols="2">(0.40-5.79) 0.047 ♦ 1.53</cell><cell>0.531</cell></row><row><cell>Serum</cell><cell>2.45</cell><cell>0.08</cell><cell>1.58</cell><cell>0.565</cell></row><row><cell>creatinine</cell><cell>(0.89 -6.72)</cell><cell></cell><cell>(0.33-7.60)</cell><cell></cell></row><row><cell>(mg/dl)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Serum</cell><cell>1.40</cell><cell>0.475</cell><cell>0.94</cell><cell>0.937</cell></row><row><cell>cystatin C</cell><cell>(0.55 -3.58)</cell><cell></cell><cell>(0.25-3.51)</cell><cell></cell></row><row><cell>(mg/L)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="5">* model adjusted for age, BMI, gestational age of delivery, parity &amp; blood pressure</cell></row><row><cell cols="4"># birth weight &lt; 2.5 kg coded as 1 and ≥ 2.5 kg coded as 0</cell><cell></cell></row><row><cell cols="2">β confidence interval</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="3">♦ Statistically Significant (P &lt; 0.05)</cell><cell></cell><cell></cell></row></table><note></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 4</head><label>4</label><figDesc></figDesc><table /><note></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head></head><label></label><figDesc>model adjusted for age, BMI, birth weight, parity &amp; blood pressure δ gestational age of delivery &lt; 37 wks. coded as 1 and ≥ 37 wks. coded as 0</figDesc><table><row><cell>Yalamati et al.</cell><cell></cell><cell></cell><cell></cell><cell>Page 12</cell></row><row><cell cols="2">Gestational age of delivery δ</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Model 1</cell><cell></cell><cell>Model 2 *</cell><cell></cell></row><row><cell cols="2">Parameter Unadjusted</cell><cell>P-</cell><cell>Adjusted</cell><cell>P-</cell></row><row><cell></cell><cell>OR (95% CI β )</cell><cell>value</cell><cell>(95% CI) OR *</cell><cell>value</cell></row><row><cell>Serum uric</cell><cell>1.54</cell><cell>0.456</cell><cell>0.79</cell><cell>0.797</cell></row><row><cell>acid</cell><cell>(0.49 -4.88)</cell><cell></cell><cell>(0.13 -</cell><cell></cell></row><row><cell>(mg/dl)</cell><cell></cell><cell></cell><cell>4.66)</cell><cell></cell></row><row><cell>Serum creatinine</cell><cell>3.60 (1.13 -</cell><cell cols="2">(0.35 -0.029 ♦ 1.93</cell><cell>0.445</cell></row><row><cell>(mg/dl)</cell><cell>11.43)</cell><cell></cell><cell>10.51)</cell><cell></cell></row><row><cell>Serum</cell><cell>2.29</cell><cell>0.143</cell><cell>1.97</cell><cell>0.391</cell></row><row><cell>cystatin C</cell><cell>(0.75 -6.99)</cell><cell></cell><cell>(0.41 -</cell><cell></cell></row><row><cell>(mg/L)</cell><cell></cell><cell></cell><cell>9.35)</cell><cell></cell></row><row><cell cols="2">β confidence interval</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="3">♦ Statistically Significant (P &lt; 0.05)</cell><cell></cell><cell></cell></row></table><note>*</note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head>Table 5</head><label>5</label><figDesc>Multivariate logistic regression.* model adjusted for age, BMI, birth weight, parity, blood pressure , gestational age of delivery £ caesarean section coded as 1 and vaginal delivery coded as 0</figDesc><table><row><cell cols="2">Mode of delivery £</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Model 1</cell><cell></cell><cell>Model 2 *</cell><cell></cell></row><row><cell cols="2">Parameter Unadjusted</cell><cell>P-</cell><cell>Adjusted</cell><cell>P-</cell></row><row><cell></cell><cell>OR (95% CI β )</cell><cell>value</cell><cell>OR * (95% CI)</cell><cell>valu e</cell></row><row><cell>Serum uric acid</cell><cell>2.93 (1.15-7.46)</cell><cell cols="2">0.024 ♦ 2.99 (0.97-9.17)</cell><cell>0.05 4</cell></row><row><cell>(mg/dl)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Serum</cell><cell>1.98</cell><cell>0.198</cell><cell>1.13</cell><cell>0.84</cell></row><row><cell>creatinine</cell><cell>(0.69-5.66)</cell><cell></cell><cell>(0.30-4.18)</cell><cell>9</cell></row><row><cell>(mg/dl)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Serum</cell><cell>2.52</cell><cell>0.055</cell><cell>2.46</cell><cell>0.10</cell></row><row><cell>cystatin C</cell><cell>(0.98-6.50)</cell><cell></cell><cell>(0.82-7.42)</cell><cell>8</cell></row><row><cell>(mg/L)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">β confidence interval</cell><cell></cell><cell></cell><cell></cell></row></table><note>♦ Statistically Significant (P &lt; 0.05)</note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Int J Reprod Contracept Obstet Gynecol. Author manuscript; available in PMC 2015 November 16.</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGEMENTS</head><p>We thank the U.S. National Institutes of Health Fogarty-supported (D43 TW009078) SHARE INDIA and University of Pittsburgh team for conducting the research method courses which contributed to the conduct and publication of this research work. We are very grateful to the nursing staff of the department of Obstetrics &amp; Gynecology and the laboratory technicians for their help in collecting and storing the samples. Also we thank Dr P S Reddy, Chairman, SHARE INDIA, MIMS and Dr Satyanarayana P, Laboratory In charge, MIMS for their support during this work.</p><p>Funding: This study was supported by the management of Mediciti Institute of Medical Sciences and partly by ICMR Short term studentship (STS) Programme</p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Author Manuscript Author Manuscript</head><p>Yalamati et al.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Author Manuscript Author Manuscript</head><p>Yalamati et al.</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<title level="m" type="main">World health report 2005: make every mother and child count. World Health</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><surname>Matthews</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2005" />
			<biblScope unit="page" from="409" to="420" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">American College of Obstetrics and Gynecology. ACOG Practice Bulletin N.33. Diagnosis and management of preeclampsia and eclampsia</title>
	</analytic>
	<monogr>
		<title level="j">Obs Gynecol</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="159" to="67" />
			<date type="published" when="2002" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">THE CLASSIFICATION AND DIAGNOSIS OF THE HYPERTENSIVE DISORDERS OF PREGNANCY: STATEMENT FROM THE INTERNATIONAL SOCIETY FOR THE STUDY OF HYPERTENSION IN PREGNANCY (ISSHP)</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mark</forename><forename type="middle">A</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marshall</forename><forename type="middle">D</forename><surname>Lindheimer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><forename type="middle">De</forename><surname>Swiet</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andre</forename><forename type="middle">Van</forename><surname>Assche</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jean-Marie</forename><surname>Moutquin</surname></persName>
		</author>
		<idno type="DOI">10.1081/prg-100104165</idno>
		<idno type="PMID">12044323</idno>
	</analytic>
	<monogr>
		<title level="j">Hypertension in Pregnancy</title>
		<idno type="ISSN">1064-1955</idno>
		<idno type="ISSNe">1525-6065</idno>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="ix" to="xiv" />
			<date type="published" when="2001" />
			<publisher>Informa UK Limited</publisher>
		</imprint>
	</monogr>
	<note>Hypertension in pregnancy: official journal of the International Society for the Study of Hypertension in Pregnancy</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">PLASMA-URATE MEASUREMENTS IN PREDICTING FETAL DEATH IN HYPERTENSIVE PREGNANCY</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">W G</forename><surname>Redman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">J</forename><surname>Beilin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Bonnar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">H</forename><surname>Wilkinson</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0140-6736(76)93024-5</idno>
		<idno type="PMID">59013</idno>
		<idno type="PII">S0140-6736(76)93024-5</idno>
		<idno type="ark">ark:/67375/6H6-NT5N1GCG-4</idno>
		<idno type="istexId">7C10399B992BBBEDC6615A11D04DA1EC5C65FF1F</idno>
	</analytic>
	<monogr>
		<title level="j">The Lancet</title>
		<title level="j" type="abbrev">The Lancet</title>
		<idno type="ISSN">0140-6736</idno>
		<imprint>
			<biblScope unit="volume">307</biblScope>
			<biblScope unit="issue">7974</biblScope>
			<biblScope unit="page" from="1370" to="1373" />
			<date type="published" when="1976-06" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Risk factors for severe preeclampsia</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">L</forename><surname>Stone</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">J</forename><surname>Lockwood</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">S</forename><surname>Berkowitz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Lapinski</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">L</forename><surname>Berkowitz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Obs Gynecol</title>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="357" to="61" />
			<date type="published" when="1994" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Uric Acid Is as Important as Proteinuria in Identifying Fetal Risk in Women With Gestational Hypertension</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">M</forename><surname>Bodnar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">Y</forename><surname>Lain</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">A</forename><surname>Hubel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Markovic</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">B</forename><surname>Ness</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">W</forename><surname>Powers</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.hyp.0000188703.27002.14</idno>
		<idno type="PMID">16246973</idno>
		<ptr type="open-access" target="https://www.ahajournals.org/doi/pdf/10.1161/01.HYP.0000188703.27002.14" />
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<title level="j" type="abbrev">Hypertension</title>
		<idno type="ISSN">0194-911X</idno>
		<idno type="ISSNe">1524-4563</idno>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1263" to="1269" />
			<date type="published" when="2005-10-24" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 16246973</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">First Trimester Uric Acid and Adverse Pregnancy Outcomes</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">K</forename><surname>Laughon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Catov</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">W</forename><surname>Powers</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">E</forename><surname>Gandley</surname></persName>
		</author>
		<idno type="DOI">10.1038/ajh.2010.262</idno>
		<idno type="PMID">21252861</idno>
		<idno type="PMCID">PMC3062659</idno>
		<ptr type="open-access" target="https://academic.oup.com/ajh/article-pdf/24/4/489/8662859/24_4_489.pdf" />
	</analytic>
	<monogr>
		<title level="j">American Journal of Hypertension</title>
		<title level="j" type="abbrev">American Journal of Hypertension</title>
		<idno type="ISSN">0895-7061</idno>
		<idno type="ISSNe">1941-7225</idno>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="489" to="495" />
			<date type="published" when="2011-04-01" />
			<publisher>Oxford University Press (OUP)</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 21252861</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Hyperuricemia facilitates the prediction of maternal and perinatal adverse outcome in patients with severe/superimposed preeclampsia</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marc</forename><surname>Parrish</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Meredith</forename><surname>Griffin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Racheal</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marie</forename><surname>Darby</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michelle</forename><forename type="middle">Y</forename><surname>Owens</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">James</forename><forename type="middle">N</forename><surname>Martin</surname></persName>
		</author>
		<idno type="DOI">10.3109/14767058.2010.500429</idno>
		<idno type="PMID">20653406</idno>
	</analytic>
	<monogr>
		<title level="j">The Journal of Maternal-Fetal &amp; Neonatal Medicine</title>
		<title level="j" type="abbrev">The Journal of Maternal-Fetal &amp; Neonatal Medicine</title>
		<idno type="ISSN">1476-7058</idno>
		<idno type="ISSNe">1476-4954</idno>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1451" to="1455" />
			<date type="published" when="2010-07-23" />
			<publisher>Informa UK Limited</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">RENAL DISEASE IN PREGNANCY</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Curtis</forename><forename type="middle">L</forename><surname>Sanders</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><forename type="middle">J</forename><surname>Lucas</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0889-8545(05)70220-5</idno>
		<idno type="PMID">11512503</idno>
		<idno type="PII">S0889-8545(05)70220-5</idno>
		<idno type="ark">ark:/67375/6H6-1RLQ8319-K</idno>
		<idno type="istexId">751DD66AFEF9E1172D03649D3254825B5599F481</idno>
	</analytic>
	<monogr>
		<title level="j">Obstetrics and Gynecology Clinics of North America</title>
		<title level="j" type="abbrev">Obstetrics and Gynecology Clinics of North America</title>
		<idno type="ISSN">0889-8545</idno>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="593" to="600" />
			<date type="published" when="2001-09" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 11512503</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Outcome of Pregnancy in Women with Moderate or Severe Renal Insufficiency</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">C</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">P</forename><surname>Hayslett</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejm199607253350402</idno>
		<idno type="PMID">8657238</idno>
	</analytic>
	<monogr>
		<title level="j">New England Journal of Medicine</title>
		<title level="j" type="abbrev">N Engl J Med</title>
		<idno type="ISSN">0028-4793</idno>
		<idno type="ISSNe">1533-4406</idno>
		<imprint>
			<biblScope unit="volume">335</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="226" to="232" />
			<date type="published" when="1996-07-25" />
			<publisher>New England Journal of Medicine (NEJM/MMS)</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 8657238</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Cystatin C and Preeclampsia: A Case Control Study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nora</forename><surname>Franceschini</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chunfang</forename><surname>Qiu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">A</forename><surname>Barrow</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michelle</forename><forename type="middle">A</forename><surname>Williams</surname></persName>
		</author>
		<idno type="DOI">10.1080/08860220701742229</idno>
		<idno type="PMID">18197549</idno>
	</analytic>
	<monogr>
		<title level="j">Renal Failure</title>
		<title level="j" type="abbrev">Renal Failure</title>
		<idno type="ISSN">0886-022X</idno>
		<idno type="ISSNe">1525-6049</idno>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="89" to="95" />
			<date type="published" when="2008-01" />
			<publisher>Informa UK Limited</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 18197549</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Differential spectrophotometry of purine compounds by means of specific enzymes; determination of adenine compounds</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Kalckar Hm</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">167</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="445" to="454" />
			<date type="published" when="1947" />
		</imprint>
	</monogr>
	<note>PubMed: 20285040</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Development of an automated kinetic Jaffé method designed to minimise bilirubin interference in plasma creatinine assays</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Martyn</forename><forename type="middle">L</forename><surname>Knapp</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Philip</forename><forename type="middle">D</forename><surname>Mayne</surname></persName>
		</author>
		<idno type="DOI">10.1016/0009-8981(87)90293-2</idno>
		<idno type="PMID">3677419</idno>
		<idno type="PII">0009-8981(87)90293-2</idno>
		<idno type="ark">ark:/67375/6H6-JMLTR5G4-6</idno>
		<idno type="istexId">8073B14DD341D1F1EE8FCAB02ECC58E1B0CD3B64</idno>
	</analytic>
	<monogr>
		<title level="j">Clinica Chimica Acta</title>
		<title level="j" type="abbrev">Clinica Chimica Acta</title>
		<idno type="ISSN">0009-8981</idno>
		<imprint>
			<biblScope unit="volume">168</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="239" to="246" />
			<date type="published" when="1987-09" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 3677419</note>
</biblStruct>

<biblStruct xml:id="b13">
	<monogr>
		<title level="m" type="main">Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the behring nephelometer systems</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Finney</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">J</forename><surname>Newman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Gruber</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Merle</forename><forename type="middle">P</forename><surname>Price</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">P</forename></persName>
		</author>
		<imprint>
			<pubPlace>BNA, BN II</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Clin Chem</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1016" to="1038" />
			<date type="published" when="1997" />
		</imprint>
	</monogr>
	<note>PubMed: 9191555</note>
</biblStruct>

<biblStruct xml:id="b15">
	<monogr>
		<title level="m" type="main">Tietz Fundamentals of Clinical Chemistry</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Amres</forename><surname>Johnson</surname></persName>
		</author>
		<editor>AE, BC.</editor>
		<imprint>
			<date type="published" when="2001" />
			<biblScope unit="page">350</biblScope>
			<pubPlace>Philadelphia</pubPlace>
		</imprint>
	</monogr>
	<note>Proteins: Analysis of proteins. 5th editio</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Renal markers in normal and hypertensive disorders of pregnancy in Indian women: a pilot study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Padma</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><forename type="middle">B</forename><surname>Aparna</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Kalpana</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Ritika</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">R</forename><surname>Sudhakar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Reprod contraception</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="514" to="534" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
	<note>Obstet Gynecol.</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Growth Monitoring Guidelines for Children from Birth to 18 Years</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><forename type="middle">V</forename><surname>Khadilkar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">V</forename><surname>Khadilkar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Choudhury</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">N</forename><surname>Agarwal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Ugra</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">K</forename><surname>Shah</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Iap</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Indian Pediatr</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="187" to="97" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
	<note>PubMed: 17413194</note>
</biblStruct>

<biblStruct xml:id="b18">
	<monogr>
		<title level="m" type="main">Section VII: Common complications of pregnancy, Preterm birth</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">G</forename><surname>Cunningham</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">F</forename><surname>Gant</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">J</forename><surname>Leveno</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">C</forename><surname>Gilstrap</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jcwk</forename><forename type="middle">Williams</forename><surname>Hauth</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Obstetrics</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2003" />
			<biblScope unit="page">690</biblScope>
			<pubPlace>New York</pubPlace>
		</imprint>
	</monogr>
	<note>Mc Graw Hill</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Accuracy of serum uric acid in predicting complications of pre-eclampsia: a systematic review</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Thangaratinam</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kmk</forename><surname>Ismail</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Sharp</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Coomarasamy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">S</forename><surname>Khan</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1471-0528.2006.00908.x</idno>
		<idno type="PMID">16553648</idno>
	</analytic>
	<monogr>
		<title level="j">BJOG: An International Journal of Obstetrics and Gynaecology</title>
		<title level="j" type="abbrev">BJOG: Int J O&amp;G</title>
		<idno type="ISSN">1470-0328</idno>
		<idno type="ISSNe">1471-0528</idno>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="369" to="378" />
			<date type="published" when="2006-04" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 16553648</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">The uric acid content of maternal and fetal blood</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jmbl</forename><surname>Siemons</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="63" to="72" />
			<date type="published" when="1917" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Hyperuricemia in pre-eclampsia</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hossam</forename><forename type="middle">E</forename><surname>Fadel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gretajo</forename><surname>Northrop</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">Robert</forename><surname>Misenhimer</surname></persName>
		</author>
		<idno type="DOI">10.1016/0002-9378(76)90786-9</idno>
		<idno type="PMID">937388</idno>
	</analytic>
	<monogr>
		<title level="j">American Journal of Obstetrics and Gynecology</title>
		<title level="j" type="abbrev">American Journal of Obstetrics and Gynecology</title>
		<idno type="ISSN">0002-9378</idno>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="640" to="647" />
			<date type="published" when="1976-07" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 937388</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Renal glomerular and tubular function in relation to the hyperuricemia of pre-eclampsia and eclampsia</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Leon</forename><forename type="middle">C</forename><surname>Chesley</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Laura</forename><forename type="middle">O</forename><surname>Williams</surname></persName>
		</author>
		<idno type="DOI">10.1016/0002-9378(45)90138-4</idno>
	</analytic>
	<monogr>
		<title level="j">American Journal of Obstetrics and Gynecology</title>
		<title level="j" type="abbrev">American Journal of Obstetrics and Gynecology</title>
		<idno type="ISSN">0002-9378</idno>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="367" to="375" />
			<date type="published" when="1945-10" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">The significance of serum uric acid, creatinine and urinary microprotein levels in predicting pre-eclampsia</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">S</forename><surname>Weerasekera</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hemantha</forename><surname>Peiris</surname></persName>
		</author>
		<idno type="DOI">10.1080/0144361021000043155</idno>
		<idno type="PMID">12623475</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Obstetrics and Gynaecology</title>
		<title level="j" type="abbrev">Journal of Obstetrics and Gynaecology</title>
		<idno type="ISSN">0144-3615</idno>
		<idno type="ISSNe">1364-6893</idno>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="17" to="19" />
			<date type="published" when="2003-01" />
			<publisher>Informa UK Limited</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 12623475</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Hyperuricemia and xanthine oxidase in preeclampsia, revisited</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Many</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">A</forename><surname>Hubel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M</forename><surname>Roberts</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0002-9378(96)70410-6</idno>
		<idno type="PMID">8572024</idno>
		<idno type="PII">S0002-9378(96)70410-6</idno>
		<idno type="ark">ark:/67375/6H6-HJ3B6M93-J</idno>
		<idno type="istexId">FA3DF5C8DAB9CAF220B75AAB761DA6D3A68626D5</idno>
	</analytic>
	<monogr>
		<title level="j">American Journal of Obstetrics and Gynecology</title>
		<title level="j" type="abbrev">American Journal of Obstetrics and Gynecology</title>
		<idno type="ISSN">0002-9378</idno>
		<imprint>
			<biblScope unit="volume">174</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="288" to="291" />
			<date type="published" when="1996-01" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 8572024</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Risk Grouping of 113 Patients with Hypertensive Disorders During Pregnancy, with Respect to Serum Urate, Proteinuria and Time of Onset of Hypertension</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Liedholm</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Montan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Åberg</surname></persName>
		</author>
		<idno type="DOI">10.3109/00016348409157122</idno>
		<idno type="ark">ark:/67375/WNG-ZXTCL5B2-B</idno>
		<idno type="istexId">9AE68F02C14D48F79421558739F4A41BAA400250</idno>
	</analytic>
	<monogr>
		<title level="j">Acta Obstetricia et Gynecologica Scandinavica</title>
		<title level="j" type="abbrev">Acta Obstet Gynecol Scand</title>
		<idno type="ISSN">0001-6349</idno>
		<idno type="ISSNe">1600-0412</idno>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="issue">s118</biblScope>
			<biblScope unit="page" from="43" to="48" />
			<date type="published" when="1984-01" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 6587728</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">THE VALUE OF BLOOD URIC ACID LEVELS IN TOXAEMIA OF PREGNANCY</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Moshe</forename><surname>Lancet</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><forename type="middle">L</forename><surname>Fisher</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1471-0528.1956.tb05447.x</idno>
	</analytic>
	<monogr>
		<title level="j">BJOG: An International Journal of Obstetrics and Gynaecology</title>
		<title level="j" type="abbrev">BJOG:An international journal of O&amp;G</title>
		<idno type="ISSN">1470-0328</idno>
		<idno type="ISSNe">1471-0528</idno>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="116" to="119" />
			<date type="published" when="1956-02" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">An evaluation of the serum uric acid level in pregnancy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Cn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Obs Gynaecol Br Commonw</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="page" from="63" to="71" />
			<date type="published" when="1963" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Elevated levels of serum uric acid, creatinine or urea in preeclamptic women</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Magna</forename><surname>Manjareeka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sitikantha</forename><surname>Nanda</surname></persName>
		</author>
		<idno type="DOI">10.5455/ijmsph.2013.2.43-47</idno>
		<ptr type="open-access" target="http://pdfs.semanticscholar.org/16c5/9b399d5d915f6b7a2f9cd5fd429cf2dfca99.pdf" />
	</analytic>
	<monogr>
		<title level="j">International Journal of Medical Science and Public Health</title>
		<title level="j" type="abbrev">Int J Med Sci Public Health</title>
		<idno type="ISSN">2320-4664</idno>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">43</biblScope>
			<date type="published" when="2013" />
			<publisher>ScopeMed International Medical Journal Management and Indexing System</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Prognostic Significance of Serum Uric Acid in Women With Gestational Hypertension</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Bellomo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Venanzi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Saronio</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Verdura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">L</forename><surname>Narducci</surname></persName>
		</author>
		<idno type="DOI">10.1161/hypertensionaha.111.177212</idno>
		<idno type="PMID">21876075</idno>
		<ptr type="open-access" target="https://www.ahajournals.org/doi/pdf/10.1161/HYPERTENSIONAHA.111.177212" />
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<title level="j" type="abbrev">Hypertension</title>
		<idno type="ISSN">0194-911X</idno>
		<idno type="ISSNe">1524-4563</idno>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="704" to="708" />
			<date type="published" when="2011-08-29" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 21876075</note>
</biblStruct>

<biblStruct xml:id="b30">
	<monogr>
		<title level="m" type="main">Relationship of Serum Uric Acid Level to Maternal and Perinatal Outcome in Patients with Hypertensive Disorders of Pregnancy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Tejal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Astha</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2014" />
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="1" to="3" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">The Correlation of Maternal Uric Acid Concentration with Small-for-Gestational-Age Fetuses in Normotensive Pregnant Women</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yoichiro</forename><surname>Akahori</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hisashi</forename><surname>Masuyama</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuji</forename><surname>Hiramatsu</surname></persName>
		</author>
		<idno type="DOI">10.1159/000332391</idno>
		<idno type="PMID">22301518</idno>
	</analytic>
	<monogr>
		<title level="j">Gynecologic and Obstetric Investigation</title>
		<title level="j" type="abbrev">Gynecol Obstet Invest</title>
		<idno type="ISSN">0378-7346</idno>
		<idno type="ISSNe">1423-002X</idno>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="162" to="167" />
			<date type="published" when="2012" />
			<publisher>S. Karger AG</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 22301518</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Serum Urate as a Predictor of Fetal Outcome in Severe Pre-Eclampsia</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Norvald</forename><surname>Sagen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kjell</forename><surname>Haram</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stein</forename><forename type="middle">Tore</forename><surname>Nilsen</surname></persName>
		</author>
		<idno type="DOI">10.3109/00016348409156277</idno>
		<idno type="PMID">6720261</idno>
		<idno type="ark">ark:/67375/WNG-T3JHM00N-S</idno>
		<idno type="istexId">C23552DE8C72C51B641FBF846DAC920141DA86E0</idno>
	</analytic>
	<monogr>
		<title level="j">Acta Obstetricia et Gynecologica Scandinavica</title>
		<title level="j" type="abbrev">Acta Obstet Gynecol Scand</title>
		<idno type="ISSN">0001-6349</idno>
		<idno type="ISSNe">1600-0412</idno>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="71" to="75" />
			<date type="published" when="1984-01" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Plasma Urate Measurements and Fetal Outcome in Preeclampsia</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Schuster</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Weppelmann</surname></persName>
		</author>
		<idno type="DOI">10.1097/00006254-198201000-00003</idno>
	</analytic>
	<monogr>
		<title level="j">Obstetrical &amp; Gynecological Survey</title>
		<title level="j" type="abbrev">Obstetrical &amp; Gynecological Survey</title>
		<idno type="ISSN">0029-7828</idno>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="11" to="12" />
			<date type="published" when="1982-01" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
	<note>PubMed: 7239351</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
